VivoSeq
Other

Wrinkles

2

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Wrinkles is an early-stage landscape with 2 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

Preclinical
No programs
Phase 12

Onabotulinum Toxin a

Walter Reed National Military Medical Center

Incobotulinum Toxin a

Northwestern University

Phase 2
No programs
Phase 3
No programs
Approved
No programs

Analysis

Trial Status

4

clinical trials

Completed2 · 50%
Unknown status1 · 25%
Active, not recruiting1 · 25%

Clinical Trials

Trial Activity

Improvement in the Appearance of Periorbital Wrinkles
Unknown status·GGoldman, Butterwick, Fitzpatrick and Groff·Phase 3·NCT05082766·20 enrolled
Evaluation of Microinjected Amnion-derived Collagen by Dermapen in the Smoothing of Skin Wrinkles
Completed·EEgyptian Atomic Energy Authority·Phase 2·NCT06054646·20 enrolled
A Comparison of 1550-nm Fractional Photothermolysis Versus Intense Focused Ultrasound for Treatment of Periorbital Wrinkles: A Pilot, Prospective Randomized Control Trial
Completed·NNorthwestern University·Phase 1·NCT01529983·20 enrolled
Treatment of Forehead/Glabellar Rhytide Complex With Onabotulinum Toxin A Versus Incobotulinum Toxin A Injection: A Split-face, Double-blinded, Randomized Control Trial
Active, not recruiting·NNorthwestern University·Phase 1·NCT02019004·20 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)